SCHEMBL1389974

SCHEMBL1389974

Cc1cc(C(C[C@H](c2ccc(-c3ccc(C(=O)O)c(Cl)c3)cc2)c2ccc(Cl)cc2F)=NO)ccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 5/20 0.58
▸ FTO Q9C0B1 1/20 0.35
▸ XDH P47989 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ ADRB1 P08588 2/20 0.34
▸ ADRB3 P13945 2/20 0.34
▸ TSHR P16473 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PRCP P42785 1/20 0.33
▸ KMO O15229 1/20 0.32
▸ FFAR1 O14842 1/20 0.32
▸ SORT1 Q99523 1/20 0.32
▸ ERCC5 P28715 1/20 0.32
▸ FEN1 P39748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL364252 1.00 GPBAR1 (0.58) GPBAR1FTOXDHPSEN1PSEN2
SCHEMBL364010 1.00 GPBAR1 (0.58) GPBAR1FTOXDHPSEN1PSEN2
SCHEMBL15949035 1.00 GPBAR1 (0.58) GPBAR1FTOXDHPSEN1PSEN2
SCHEMBL1390482 1.00 GPBAR1 (0.58) GPBAR1FTOXDHPSEN1PSEN2
SCHEMBL362306 1.00 GPBAR1 (0.58) GPBAR1FTOXDHPSEN1PSEN2
SCHEMBL1389712 1.00 GPBAR1 (0.58) GPBAR1FTOXDHPSEN1PSEN2
SCHEMBL363003 0.95 GPBAR1 (0.58) GPBAR1FTOPSEN1PSEN2APH1B
SCHEMBL1390008 0.95 GPBAR1 (0.58) GPBAR1FTOPSEN1PSEN2APH1B
SCHEMBL362667 0.95 GPBAR1 (0.58) GPBAR1FTOPSEN1PSEN2APH1B
SCHEMBL1389951 0.95 GPBAR1 (0.58) GPBAR1FTOPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 — — US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885FTO 2307/4885XDH 2189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback